Skip to content

Education and Employment focused Individual Placement and Support (IPS) for young people with an 'at risk mental state' for psychosis: a feasibility study

Individual placement and support in early psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN13549282
Enrollment
25
Registered
2019-12-05
Start date
2019-06-01
Completion date
Unknown
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis Mental and Behavioural Disorders Psychosis

Interventions

The IPS intervention is an individualised approach which involves intensive, individual support to re-engage or stay in education or employment. Depending on the client's needs and preference, this ca
support in preparing job or school applications
preparing CV
practicing for interviews
and joining the client in appointments when they request support (e.g. work place, educational institution, job centre). None of the information collected as part of this research study will be shared

Sponsors

King's College London
Lead Sponsor
South London & Maudsley NHS Fundation Trust
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Met criteria for being at clinical high risk of psychosis at some point within the previous 12 months of the commencement of the study and would have been under the care of the OASIS teams 2. Aged 16-40 years 3. Provide informed consent 4. Express interest in vocational/educational support 5. At least 12 months of treatment remaining with the OASIS team

Exclusion criteria

Exclusion criteria: 1. Unable to fully comprehend the purpose of the study or make a rational decision whether or not to participate (i.e. not 'Gillick competent') 2. Antipsychotic medication for > 30 days (cumulative number of days) in the 3 months before the baseline assessments (including self-ratings and screening assessments), at doses that would be adequate for treating a first episode of psychosis (i.e. excludes very low doses) 3. Any past episode of frank psychosis lasting > 7 days

Design outcomes

Primary

MeasureTime frame
Feasibility of the intervention assessed using: 1. Evidence of the acceptability assessed by interviews 2. Feasibility of delivering the intervention and conducting the research assessment assessed using data integrity 3. Willingness to be recruited, take part in the intervention and drop-out rate measured using consent forms and records 4. Number of eligible participants 5. Willingness to be re-assessed after the intervention (at every follow-up participants will be asked if they wish to be reassessed) 6. Standard deviation of the secondary outcome measures to estimate the sample size for the definitive trial 7. Research and intervention resources, including training and supervision, necessary for delivering the IPS intervention 8. Rates of employment/enrolment on educational course at 3 and 6 months follow up

Secondary

MeasureTime frame
At baseline, 3 months and 6 months: 1. Symptoms of psychosis or attenuated symptoms of psychosis measured using the CAARMS 2. Self-efficacy measured using the General Self-Efficacy Scale 3. Functioning assessed using the Global Assessment of Functioning and Social and Occupational Functioning Scale 4. How participants use their time measured using the Time Use Survey (TUS) 5. Health and social aspects measured using the Health of the Nation Outcome Scale (HoNOS)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026